Literature DB >> 7772877

Etiology and management of chronic valve disease in antiphospholipid antibody syndrome and systemic lupus erythematosus.

D M Shahian1, S B Labib, A B Schneebaum.   

Abstract

Unlike the Libman-Sacks vegetations of acute systemic lupus erythematosus (SLE), which are usually asymptomatic, valve involvement in chronic SLE and primary antiphospholipid antibody syndrome (APLAS) is similar to that of chronic rheumatic disease. Typical findings include valve thickening and nodularity, poor coaptation, and regurgitation. Elevated levels of antiphospholipid antibodies have been associated with the development of these valvular abnormalities in some but not all reported cases, and there are undoubtedly other etiologic cofactors. When cardiac valvular replacement is required, special attention must be given to preoperative reduction of elevated antibody levels, prevention of intraoperative thromboembolism, and prompt and aggressive postoperative anticoagulation.

Entities:  

Mesh:

Year:  1995        PMID: 7772877     DOI: 10.1111/j.1540-8191.1995.tb01231.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  6 in total

Review 1.  Current treatment of antiphospholipid syndrome: lights and shadows.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Nat Rev Rheumatol       Date:  2015-06-30       Impact factor: 20.543

Review 2.  Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.

Authors:  Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2010-03-23       Impact factor: 1.637

3.  Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies.

Authors:  Piotr Leszczyński; Ewa Straburzyńska-Migaj; Izabela Korczowska; Jan K Łacki; Stefan Mackiewicz
Journal:  Clin Rheumatol       Date:  2003-10-14       Impact factor: 2.980

Review 4.  Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis.

Authors:  M C Amigo; R García-Torres
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.686

5.  Systemic lupus erythematosus and systemic autoimmune connective tissue disorders behind recurrent diastolic heart failure.

Authors:  Luis Miguel Blasco Mata; Olga Acha Salazar; Carmen Rosa González-Fernández; Francisco Novo Robledo; Enrique Pérez-Llantada Amunárriz
Journal:  Clin Dev Immunol       Date:  2011-09-21

Review 6.  Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.

Authors:  Atiya Dhala
Journal:  Clin Dev Immunol       Date:  2012-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.